Lompat ke konten Lompat ke sidebar Lompat ke footer

Get Bridging Therapy For Anticoagulation US

Get Bridging Therapy For Anticoagulation US. Whether or not to bridge with heparin or other anticoagulants is a common clinical dilemma. (see 'timing of anticoagulant interruption' below and 'bridging anticoagulation' below and 'temporary ivc filters' below.) ●in the bridge trial (bridging anticoagulation in patients who require temporary interruption of warfarin therapy for an elective invasive procedure or surgery).

Warfarin Bridging
Warfarin Bridging from image.slidesharecdn.com
Receiving warfarin therapy for at least 3 months, administered to achieve an international normalized ratio (inr) range of 2.0 to 3.0. · reversal of anticoagulant therapy for urgent surgery. Patients were randomly assigned to receive bridging anticoagulation therapy with dalteparin sodium (100 iu per kilogram of body weight administered subcutaneously twice daily) or to receive no bridging therapy (i.e., a matching subcutaneous placebo) from 3 days before the procedure until 24 hours.

Receiving warfarin therapy for at least 3 months, administered to achieve an international normalized ratio (inr) range of 2.0 to 3.0.

Patients were followed up prospectively during their inpatient stay. Bridging anticoagulant therapy is appropriate for some but not all patients undergoing medical procedures. Key issues in bridging therapy include identifying patients who can safely undergo an invasive procedure while continuing their vitamin k antagonist, identifying those who will likely gain the most benefit from bridging anticoagulation. Heparin prevents coagulation by activating antithrombin.

Posting Komentar untuk "Get Bridging Therapy For Anticoagulation US"